Research Article
Molecular Analysis of CYP21A2 Gene Mutations among Iraqi Patients with Congenital Adrenal Hyperplasia
Table 6
Frequency of common allelic mutations in this study compared with previous studies from some of the neighboring and Arab countries.
| | Present study, Iraq, 2015 | Turkey, 2009 [10] | Jordan, 2011 [11] | Iran, 2011 [12] | Iran, 2008 [13] | Tunisia, 2004 [14] |
| Total alleles () | 124 | 91 | 92 | 88 | 100 | 102 | Not detected (%) | 39.5% | 15.4% | 40% | 0 | 30% | 5.9% | Molecular method(s) used | AS-PCR with reverse hybridization for 11 mutations | SB, AS-PCR/ER, and sequencing | ARMS for 8 common mutations & MLPA | AS-PCR for 8 common mutations and sequencing | AS-PCR for 8 mutations | ER + sequencing | P30L | 0 | 0 | 17.8 | 0 | 0 | 0 | I2Splice | 14.5 | 22.0 | 35.7 | 14.77 | 28 | 17.6 | Del 8 bp E3 | 3.2 | 4.4 | 16 | 0 | 13 | 0 | I172N | 8.1 | 9.9 | 16 | 5.68 | 9.0 | 10.8 | Cluster E6 | 0 | 2.2 | 1.7 | 2.27 | 4.0 | 0 | V281L | 4.0 | 7.6 | 0 | 1.14 | 3.0 | 0 | L307fs | 0 | 0 | NT | 0 | NT | 0 | Q318X | 11.3 | 3.3 | 23.2 | 15.91 | 9 | 35.3 | R356W | 0 | 8.8 | 3.5 | 7.95 | 5.0 | 2.0 | P453S | 0.81 | 2.2 | NT | NR | NT | NR | R483P | 0.81 | NR | NT | NR | NT | | Deletions/conversions | 19.3 | 8.8/14.3 | 0 | 31.8 | NT | 19.6 |
|
|
NR: not reported; NT: not tested; SB: southern blot; AS-PCR: allele-specific oligonucleotide hybridization by PCR; ER: enzyme restriction; ARMS: amplification refractory mutational screen; MLPA: multiplex ligation dependent probe amplification.
|